2004
DOI: 10.1016/j.tox.2004.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…SM-induced skin injury appears to be mediated in part through neurogenic inflammatory processes [7,8]; therefore, it is possible that NPY Y 1 could also contribute to dermal inflammation following exposure to SM. Recently, we have demonstrated the potential role of substance P in SMinduced skin injury, which is reduced by pretreatment with olvanil [80].…”
Section: Discussionmentioning
confidence: 99%
“…SM-induced skin injury appears to be mediated in part through neurogenic inflammatory processes [7,8]; therefore, it is possible that NPY Y 1 could also contribute to dermal inflammation following exposure to SM. Recently, we have demonstrated the potential role of substance P in SMinduced skin injury, which is reduced by pretreatment with olvanil [80].…”
Section: Discussionmentioning
confidence: 99%
“…CGRP and Substance P activate immune cells and induce inflammatory tissue responses such as swelling, vasodilation, increase in blood flow and edema (Beard and Beard, 1989). In a mouse model of SM skin injury, pre-exposure treatment with olvanil, a TRPV1 ligand causing depletion of inflammatory neuropeptides, attenuated skin inflammation and edema and reduced Substance P immunoreactivity in the skin, suggesting that neurogenic inflammation contributes to the cutaneous toxicological effects of SM (Babin et al, 2000; Casbohm et al, 2004; Sabourin et al, 2003). Neurogenic inflammation mediated by CGRP has been implicated in trigeminal pain and migraine, leading to the development of CGRP receptor inhibitors that showed promising preclinical and clinical efficacy (Bell et al, 2012; Romero-Reyes et al, 2015; Voss et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Edema can be quantified by measuring 8-mm-diameter ear punch biopsy weights. This model has been used to screen many compounds and remains the most cost-effective live animal screen available (Casillas et al, 2000a,b;Dachir et al, 2002Dachir et al, , 2004aBabin et al, 2003;Casbohm et al, 2004;Sabourin et al, 2004;Wormser et al, 2004aWormser et al, ,b, 2005Kiser et al, 2005;Amitai et al, 2006;Dillman et al, 2006). These effects occur in a dose-dependent manner (Figure 39.4).…”
Section: Model Systems For Screening Smmentioning
confidence: 99%
“…Capsaicin and its structural analogs, known collectively as vanilloids, have been shown to have anti-inflammatory activity, as demonstrated by inhibition of edema, mast cell degranulation, and leukocyte migration (Brand et al, 1990;Bunker et al, 1991). Analogs octyl homovanillamide and heptyl isovanillamide were shown to display similar protective activities against SM (Casbohm et al, 2004). One such vanilloid, olvanil, is a highly lipophilic analog of capsaicin and has been shown to reduce SM-induced histological damage and edema as well as cytokine and chemokine mRNA induction (Casillas et al, 2000a,b;Sabourin et al, 2003).…”
Section: Trpv1 Ligandsmentioning
confidence: 99%